US · Healthcare · Biotechnology
EPS came in at -0.31 against a street estimate of -0.27 — a miss of 14.8%.
Analysts rate Seer Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $4.00.
| Fund | Stake |
|---|---|
| SoftBank Group Corp | 9.27% |
| Siren, L.L.C. | 4.44% |
| Acadian Asset Management LLC | 3.53% |
| Vanguard Capital Management, LLC | 3.31% |
| BlackRock Inc | 2.58% |
| Renaissance Technologies Corp | 1.78% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.49% |
| Citadel Advisors Llc | 0.94% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Seer Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.